CUSP06/AMT-707, a new CDH6-targeting antibody-drug conjugate, demonstrates potent antitumor activity in preclinical models

被引：0
|
作者：
Lu, Wei
Shi, Jing
Liu, Shu-Hui
Covino, Nicole
Meng, Xun
Slosberg, Eric D.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6320
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6320
引用
收藏
页数：2
相关论文
共 50 条
  • [31] In vivo activity of a novel CDH6 targeting antibody-drug conjugate, including population-scale ovarian PDX clinical trial
    Bialucha, Carl U.
    Collins, Scott D.
    Shim, Yeonju
    Zhang, Xiamei
    Velazquez, Roberto
    Kowa, Colleen
    Bullock, Caroline
    Cai, Hongbo
    Rivera, Stacy M.
    Goldovitz, Julie M.
    Kurth, Esther
    Loo, Alice T.
    Yang, Guizhi
    Green, John
    Ostrom, Lance
    Meyer, Matthew J.
    Mosher, Rebecca
    Gao, Hui
    Williams, Juliet
    Lees, Emma
    CANCER RESEARCH, 2016, 76
  • [32] A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
    Zhu, Xiao-yi
    Li, Quan-xiao
    Kong, Yu
    Huang, Ke-ke
    Wang, Gang
    Wang, Yun-ji
    Lu, Jun
    Hua, Guo-qiang
    Wu, Yan-ling
    Ying, Tian-lei
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (03) : 609 - 618
  • [33] A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
    Xiao-yi Zhu
    Quan-xiao Li
    Yu Kong
    Ke-ke Huang
    Gang Wang
    Yun-ji Wang
    Jun Lu
    Guo-qiang Hua
    Yan-ling Wu
    Tian-lei Ying
    Acta Pharmacologica Sinica, 2024, 45 : 609 - 618
  • [34] ZW251, a novel glypican-3-targeting antibody-drug conjugate bearing a topoisomerase I inhibitor payload demonstrates compelling preclinical activity in hepatocellular carcinoma models
    Madera, L.
    Wu, A.
    Bissessur, A.
    Chan, A.
    Cheng, C. W.
    Yin, K.
    Alonzo, D. A.
    Tsui, J.
    Sim, D.
    Wu, K.
    Urosev, D.
    Petersen, M. E.
    Hershberger, S.
    Stahl, K.
    Rojas, A. Hernandez
    Fung, V.
    Colombo, R.
    Barnscher, S. D.
    Rich, J. R.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S70 - S70
  • [35] Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer
    Matsuzaki, Satoko
    Serada, Satoshi
    Hiramatsu, Kosuke
    Nojima, Satoshi
    Matsuzaki, Shinya
    Ueda, Yutaka
    Ohkawara, Tomoharu
    Mabuchi, Seiji
    Fujimoto, Minoru
    Morii, Eiichi
    Yoshino, Kiyoshi
    Kimura, Tadashi
    Naka, Tetsuji
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (05) : 1056 - 1066
  • [36] BCG016, a first-in-class bispecific antibody-drug conjugate targeting 5T4 and MUC1, demonstrates potent preclinical anti-tumor activity
    Han, Zhenyan
    Shang, Chengzhang
    Zhang, Yifu
    An, Gao
    Guo, Chaoshe
    An, W. Frank
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [37] DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody-Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models
    Yamato, Michiko
    Hasegawa, Jun
    Maejima, Takanori
    Hattori, Chiharu
    Kumagai, Kazuyoshi
    Watanabe, Akiko
    Nishiya, Yumi
    Shibutani, Tomoko
    Aida, Tetsuo
    Hayakawa, Ichiro
    Nakada, Takashi
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (04) : 635 - 646
  • [38] IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors
    Ab, Olga
    Whiteman, Kathleen R.
    Bartle, Laura M.
    Sun, Xiuxia
    Singh, Rajeeva
    Tavares, Daniel
    LaBelle, Alyssa
    Payne, Gillian
    Lutz, Robert J.
    Pinkas, Jan
    Goldmacher, Victor S.
    Chittenden, Thomas
    Lambert, John M.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07) : 1605 - 1613
  • [39] PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies
    Sheng, Qing
    D'Alessio, Joseph A.
    Menezes, Daniel L.
    Karim, Christopher
    Tang, Yan
    Tam, Angela
    Clark, Suzanna
    Ying, Chi
    Connor, Anu
    Mansfield, Keith G.
    Rondeau, Jean-Michel
    Ghoddusi, Majid
    Geyer, Felipe C.
    Gu, Jane
    McLaughlin, Margaret E.
    Newcombe, Rick
    Elliot, GiNell
    Tschantz, William R.
    Lehmann, Sylvie
    Fanton, Christie P.
    Miller, Kathy
    Huber, Thomas
    Rendahl, Katherine G.
    Jeffry, Ursula
    Pryer, Nancy K.
    Lees, Emma
    Kwon, Paul
    Abraham, Judith A.
    Damiano, Jason S.
    Abrams, Tinya J.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (07) : 1270 - 1282
  • [40] Preclinical antitumor activity of an anti-HER2/Trop-2 bispecific antibody-drug conjugate with a new DNA topoisomerase I inhibitor
    Zhong, Helen
    Xiong, Yan
    Huang, Han
    Pan, Yuming
    Cao, Lijin
    Liu, Shen
    Wang, Na
    Sun, Bing
    Liu, Dingguo
    Yuan, Wei
    Fang, Jan
    Bao, Haifeng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345